Structure expects pills to capture 25% to 50% of GLP-1 obesity market by 2030

Structure Therapeutics

14/01/2026 19:58

Jan 14 (Reuters) - Structure Therapeutics GPCR.O said on Wednesday that it expects oral weight-loss drugs to capture 25% to 50% of the GLP-1 market by 2030, a bullish estimate the CEO said was driven partly by pent-up demand for a pill from patients and doctors.

 (Reporting by Puyaan Singh in Bengaluru; Editing by Sahal Muhammed)

 ((Puyaan.Singh@thomsonreuters.com;))